本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Olema Pharmaceuticals, Inc.

5.82
+0.36006.59%
成交量:14.17万
成交额:81.82万
市值:3.99亿
市盈率:-3.01
高:5.97
开:5.48
低:5.36
收:5.46
52周最高:13.93
52周最低:2.86
股本:6,863.43万
流通股本:3,964.53万
量比:1.98
换手率:0.36%
股息:- -
股息率:- -
每股收益(TTM):-1.9357
每股收益(LYR):-2.2041
净资产收益率:-49.72%
总资产收益率:-29.87%
市净率:1.16
市盈率(LYR):-2.64

数据加载中...

2024/12/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/10

重要事件披露

Form 8-K - Current report
2024/12/04

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/12/02

重要事件披露

Form 8-K - Current report
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/13

重要事件披露

Form 8-K - Current report
2024/09/27

重要事件披露

Form 8-K - Current report
2024/08/06

重要事件披露

Form 8-K - Current report
2024/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/02

重要事件披露

Form 8-K - Current report